For the modern clinician, documentation has become one of the most time-consuming aspects of daily practice. While structured artificial intelligence tools can reduce administrative overhead by up to 50%,* navigating this transition safely requires a definitive professional framework.
The Accreditation Council for Continuing Medical Education (ACCME) has issued an urgent national directive establishing an unshakeable boundary: clinical accuracy, patient safety, and data stewardship remain strictly non-transferable human responsibilities. Because generative language models are fundamentally probabilistic engines—even when wrapped in specialized enterprise medical software—you remain completely liable for any “AI hallucinations,” critical omissions, or diagnostic logic errors signed into your charts.
Clinical and legal accountability never transfers to a machine—final responsibility always rests entirely on you.
This case-driven, on-demand enduring curriculum transitions you from a passive technology consumer to a critical “Human-in-the-Loop” safeguard, allowing you to capture massive efficiency gains while securely shielding your medical license and your patients.
Apply the “De-Identification Habit Shift” using hands-on clinical before-and-after scenarios. Learn to seamlessly strip out personal patient identifiers from unstructured notes to safeguard patient privacy and support HIPAA-compliant workflows.
Master the structured COSTAR prompting framework to achieve reliable, high-quality outputs from generative AI. Access an evidence-based roadmap for safely streamlining administrative tasks, chart summaries, and patient education materials.
After completing this activity, participants should be able to:
Define clinical AI literacy.
Identify common opportunities for AI usage in clinical workflows
Apply a “human-in-the-loop” framework to manage clinical AI risks, including hallucinations.
Apply de-identification rules before using AI tools with patient-related information to protect privacy.
Use the structured COSTAR prompting framework to safely draft clinical notes and patient education materials.
This activity is intended for physicians, nurses, and pharmacists with an interest in AI literacy, HIPAA-compliant AI use, responsible prompting, and practical clinical workflow improvement.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and AI Prophets. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physicians (ACCME)
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses (ANCC)
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.
Pharmacists (ACPE)
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number- JA4008162-9999-26-490-H99-P
Type of Activity: Knowledge
Deirdre Andrews, MD
Hunterdon Health Care
Washington, NJ
Soumen Samaddar, MD, DABFM, FAAFP
Hunterdon Family and Sports Medicine at Hopewell Valley
Pennington, NJ
Mark Andrews, MSc
AI Prophets
Milford, NJ
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified financial relationships are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited education and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. All relevant financial relationships have been mitigated.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
• Dr. Andrews has nothing to disclose.
• Dr. Samaddar disclosed stock ownership in Pfizer, Galectin Therapeutics, and Service Now.
• Mark Andrews has nothing to disclose.
The PIM planners and others have nothing to disclose. The AI Prophets planners and others have nothing to disclose.
All relevant financial relationships have been mitigated.
Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Provide your clinical staff, medical society members, or state association chapters with preferred enterprise access to our PIM-accredited AI Literacy curriculum. Complete the intake assessment below to request a tailored volume pricing proposal.